Pharmacokinetics and Safety of GST-HG171 Tablets in Subjects With Impaired and Normal Liver Function

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
This si a single-center, non-randomized, open, parallel, single-dose trial was designed to evaluate the safety and pharmacokinetic characteristics of GST-HG171 tablets in subjects with impaired liver function.
Epistemonikos ID: c4ee5655af229bc90145e8744ba9ac2d74c15a07
First added on: Oct 31, 2023